Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with alzheimer's disease

Alberto Cornejo, José M. Jiménez, Leonardo Caballero, Francisco Melo, Ricardo B. MacCioni

Resultado de la investigación: Article

33 Citas (Scopus)

Resumen

Alzheimer's disease is a neurodegenerative disorder involving extracellular plaques (amyloid-β) and intracellular tangles of tau protein. Recently, tangle formation has been identified as a major event involved in the neurodegenerative process, due to the conversion of either soluble peptides or oligomers into insoluble filaments. At present, the current therapeutic strategies are aimed at natural phytocomplexes and polyphenolics compounds able to either inhibit the formation of tau filaments or disaggregate them. However, only a few polyphenolic molecules have emerged to prevent tau aggregation, and natural drugs targeting tau have not been approved yet. Fulvic acid, a humic substance, has several nutraceutical properties with potential activity to protect cognitive impairment. In this work we provide evidence to show that the aggregation process of tau protein, forming paired helical filaments (PHFs) in vitro, is inhibited by fulvic acid affecting the length of fibrils and their morphology. In addition, we investigated whether fulvic acid is capable of disassembling preformed PHFs. We show that the fulvic acid is an active compound against preformed fibrils affecting the whole structure by diminishing length of PHFs and probably acting at the hydrophobic level, as we observed by atomic force techniques. Thus, fulvic acid is likely to provide new insights in the development of potential treatments for Alzheimer's disease using natural products.

Idioma originalEnglish
Páginas (desde-hasta)143-153
Número de páginas11
PublicaciónJournal of Alzheimer's Disease
Volumen27
N.º1
DOI
EstadoPublished - 2011

Huella dactilar

Alzheimer Disease
tau Proteins
Humic Substances
Amyloid Plaques
Drug Delivery Systems
Dietary Supplements
Biological Products
Neurodegenerative Diseases
fulvic acid
Peptides
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology
  • Medicine(all)

Citar esto

Cornejo, Alberto ; Jiménez, José M. ; Caballero, Leonardo ; Melo, Francisco ; MacCioni, Ricardo B. / Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with alzheimer's disease. En: Journal of Alzheimer's Disease. 2011 ; Vol. 27, N.º 1. pp. 143-153.
@article{1690a9572a3d4fd99440696c4538d11b,
title = "Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with alzheimer's disease",
abstract = "Alzheimer's disease is a neurodegenerative disorder involving extracellular plaques (amyloid-β) and intracellular tangles of tau protein. Recently, tangle formation has been identified as a major event involved in the neurodegenerative process, due to the conversion of either soluble peptides or oligomers into insoluble filaments. At present, the current therapeutic strategies are aimed at natural phytocomplexes and polyphenolics compounds able to either inhibit the formation of tau filaments or disaggregate them. However, only a few polyphenolic molecules have emerged to prevent tau aggregation, and natural drugs targeting tau have not been approved yet. Fulvic acid, a humic substance, has several nutraceutical properties with potential activity to protect cognitive impairment. In this work we provide evidence to show that the aggregation process of tau protein, forming paired helical filaments (PHFs) in vitro, is inhibited by fulvic acid affecting the length of fibrils and their morphology. In addition, we investigated whether fulvic acid is capable of disassembling preformed PHFs. We show that the fulvic acid is an active compound against preformed fibrils affecting the whole structure by diminishing length of PHFs and probably acting at the hydrophobic level, as we observed by atomic force techniques. Thus, fulvic acid is likely to provide new insights in the development of potential treatments for Alzheimer's disease using natural products.",
keywords = "Alzheimer's disease, atomic force microscopy, disassembly, fulvic acid, tau aggregation",
author = "Alberto Cornejo and Jim{\'e}nez, {Jos{\'e} M.} and Leonardo Caballero and Francisco Melo and MacCioni, {Ricardo B.}",
year = "2011",
doi = "10.3233/JAD-2011-110623",
language = "English",
volume = "27",
pages = "143--153",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "1",

}

Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with alzheimer's disease. / Cornejo, Alberto; Jiménez, José M.; Caballero, Leonardo; Melo, Francisco; MacCioni, Ricardo B.

En: Journal of Alzheimer's Disease, Vol. 27, N.º 1, 2011, p. 143-153.

Resultado de la investigación: Article

TY - JOUR

T1 - Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with alzheimer's disease

AU - Cornejo, Alberto

AU - Jiménez, José M.

AU - Caballero, Leonardo

AU - Melo, Francisco

AU - MacCioni, Ricardo B.

PY - 2011

Y1 - 2011

N2 - Alzheimer's disease is a neurodegenerative disorder involving extracellular plaques (amyloid-β) and intracellular tangles of tau protein. Recently, tangle formation has been identified as a major event involved in the neurodegenerative process, due to the conversion of either soluble peptides or oligomers into insoluble filaments. At present, the current therapeutic strategies are aimed at natural phytocomplexes and polyphenolics compounds able to either inhibit the formation of tau filaments or disaggregate them. However, only a few polyphenolic molecules have emerged to prevent tau aggregation, and natural drugs targeting tau have not been approved yet. Fulvic acid, a humic substance, has several nutraceutical properties with potential activity to protect cognitive impairment. In this work we provide evidence to show that the aggregation process of tau protein, forming paired helical filaments (PHFs) in vitro, is inhibited by fulvic acid affecting the length of fibrils and their morphology. In addition, we investigated whether fulvic acid is capable of disassembling preformed PHFs. We show that the fulvic acid is an active compound against preformed fibrils affecting the whole structure by diminishing length of PHFs and probably acting at the hydrophobic level, as we observed by atomic force techniques. Thus, fulvic acid is likely to provide new insights in the development of potential treatments for Alzheimer's disease using natural products.

AB - Alzheimer's disease is a neurodegenerative disorder involving extracellular plaques (amyloid-β) and intracellular tangles of tau protein. Recently, tangle formation has been identified as a major event involved in the neurodegenerative process, due to the conversion of either soluble peptides or oligomers into insoluble filaments. At present, the current therapeutic strategies are aimed at natural phytocomplexes and polyphenolics compounds able to either inhibit the formation of tau filaments or disaggregate them. However, only a few polyphenolic molecules have emerged to prevent tau aggregation, and natural drugs targeting tau have not been approved yet. Fulvic acid, a humic substance, has several nutraceutical properties with potential activity to protect cognitive impairment. In this work we provide evidence to show that the aggregation process of tau protein, forming paired helical filaments (PHFs) in vitro, is inhibited by fulvic acid affecting the length of fibrils and their morphology. In addition, we investigated whether fulvic acid is capable of disassembling preformed PHFs. We show that the fulvic acid is an active compound against preformed fibrils affecting the whole structure by diminishing length of PHFs and probably acting at the hydrophobic level, as we observed by atomic force techniques. Thus, fulvic acid is likely to provide new insights in the development of potential treatments for Alzheimer's disease using natural products.

KW - Alzheimer's disease

KW - atomic force microscopy

KW - disassembly

KW - fulvic acid

KW - tau aggregation

UR - http://www.scopus.com/inward/record.url?scp=80155161291&partnerID=8YFLogxK

U2 - 10.3233/JAD-2011-110623

DO - 10.3233/JAD-2011-110623

M3 - Article

VL - 27

SP - 143

EP - 153

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 1

ER -